Rapid Diagnostics for Rheumatoid Arthritis Study Published in Journal of Medical Economics Article

PHE recently published a new study in collaboration with Genalyte on the potential value of rapid, cloud-enabled, onsite laboratory testing for the diagnosis of rheumatoid arthritis. The study found that this technology could generate value of over $5,000 per evaluated patient-year. The study was led by PHE’s Kata Bognar, Jason Shafrin, Michelle Brauer, Lauren Zhao, and Bapu Jena.

To read the study abstract, please click the link below:

The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States. Journal of Medical Economics, 2018. https://doi.org/10.1080/13696998.2018.1502191

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.